| Adverse Drug Events Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Mar/Apr 2024
Pg. 100-109
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
Mar/Apr 2024
Pg. 118-119
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jan/Feb 2024
Pg. 16-21
|
Drug Utilization Review: Our Patients Deserve Our Very Best
Jackson Kathleen
|
Nov/Dec 2023
Pg. 450-453
|
Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 483-486
|
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
|
Sep/Oct 2023
Pg. 358-360
|
Compounding Metformin for Use in Functional Medicine
Desai Sarina, Thompson Tara
|
Sep/Oct 2023
Pg. 362-366
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Riepl Mike, Kaiser Joe
|
Sep/Oct 2023
Pg. 368-380
|
Excipients and Adverse Events
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 382-385
|
Topical Vehicles: A Dermatologist's Perspective
Adame Stephanie, Collins Michael E, Korman Abraham M
|
Jul/Aug 2023
Pg. 278-283
|
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 30-37
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 385-395
|
Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease
Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
|
Sep/Oct 2022
Pg. 436-439
|
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Summers Amy
|
Jul/Aug 2022
Pg. 309-315
|
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 34-38
|
Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
|
Jan/Feb 2022
Pg. 72-79
|
It's Time for a New Philosophy
Brunner Scott
|
Sep/Oct 2021
Pg. 386-387
|
Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists
Kiselova Olga, Maurina Baiba, Sidlovska Venta
|
Jul/Aug 2021
Pg. 288-295
|
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
|
Mar/Apr 2021
Pg. 146-155
|
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 31-38
|
Low-dose Naltrexone Therapy for Psoriasis
Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
|
Mar/Apr 2020
Pg. 94-96
|
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 133
|
Basics: Excipients Used in Nonsterile Compounding, Part 1
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 305-311
|
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L, York Anne E
|
Jul/Aug 2019
Pg. 325-339
|
How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
|
May/Jun 2019
Pg. 182-186
|
PreScription: Compounding with Cannabidiol
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 92
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
|
Mar/Apr 2019
Pg. 94-104
|
Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
|
Mar/Apr 2019
Pg. 106-111
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
|
Jan/Feb 2019
Pg. 23-31
|
Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 35-44
|
Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding
Martin Matt
|
Jan/Feb 2019
Pg. 47-49
|
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 54
|
Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 55
|
PreScription: Standardized Concentrations: Pro or Con?
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 444
|
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications
Zur Eyal
|
Nov/Dec 2018
Pg. 446-454
|
Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
|
Sep/Oct 2018
Pg. 358-366
|
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
|
May/Jun 2018
Pg. 237
|
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
|
Mar/Apr 2018
Pg. 172-175
|
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
|
Jul/Aug 2017
Pg. 282-289
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
|
Jan/Feb 2017
Pg. 6-16
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
|
Nov/Dec 2016
Pg. 447-454
|
PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution
Rost Erika
|
Nov/Dec 2016
Pg. 526-527
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 389-396
|
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M, Collin Michael
|
May/Jun 2016
Pg. 197-201
|
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration
Akers Michael J
|
May/Jun 2016
Pg. 217-222
|
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance
Miller David G
|
Nov/Dec 2015
Pg. 449-450
|
Root Cause Analysis, Part 1: Nonsterile Compounding
Cabaleiro Joe, Jackson Kathleen
|
Nov/Dec 2015
Pg. 465-469
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters
Puertos Enrique, Spencer Melissa
|
Jul/Aug 2015
Pg. 334-336
|
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes
Anderson Collin R, Halford Zachery, MacKay Mark
|
Jul/Aug 2015
Pg. 344-347
|
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R, Davidson Gigi S
|
Sep/Oct 2014
Pg. 366-369
|
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
|
Sep/Oct 2014
Pg. 418-426
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation
Phan Ha, DeReese Annie, Day A J, Carvalho Maria
|
May/Jun 2014
Pg. 203-207
|
Mesna 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 420
|
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Wung Deanna
|
Jan/Feb 2013
Pg. 24-27
|
Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
|
Jul/Aug 2012
Pg. 276-286
|
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
|
Nov/Dec 2011
Pg. 526-527
|
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
|
Jul/Aug 2011
Pg. 290-300
|
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine
Bramwell Bethany L
|
Mar/Apr 2011
Pg. 174-175
|
Maillard Reactions in Pharmaceutical Formulations and Human Health
Newton David W
|
Jan/Feb 2011
Pg. 32-40
|
Toxicities Associated with Topical Anesthetics
Bramwell Bethany L
|
Jan/Feb 2011
Pg. 41
|
Marketing Vitamins, Minerals, and Other Nutrients
Kress Robert B
|
Jan/Feb 2011
Pg. 44-47
|
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 71
|
Bioidentical Hormones in the News
Bramwell Bethany L
|
Sep/Oct 2010
Pg. 374-380
|
Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 328-331
|
Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword?
Williams LaVonn A
|
Mar/Apr 2010
Pg. 105-107
|
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
|
Mar/Apr 2010
Pg. 165-170
|
Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
Ploesser Jennifer, Weinstock Leonard B, Thomas Erin
|
Mar/Apr 2010
Pg. 171-173
|
When Traditional Medicine Fails
Bash Robert
|
Jan/Feb 2010
Pg. 6-8
|
Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting
McElhiney Linda F
|
Jan/Feb 2010
Pg. 32-38
|
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
|
Jul/Aug 2009
Pg. 314-317
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jul/Aug 2009
Pg. 270-275
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
May/Jun 2009
Pg. 218-219
|
Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
|
Sep/Oct 2008
Pg. 384-390
|
Equine Anesthesia: Triple Drip
Davidson Gigi S
|
Sep/Oct 2008
Pg. 402-404
|
Excipient Choices for Special Populations
Nagel-Edwards Karen M, Ko James Y
|
Sep/Oct 2008
Pg. 426-430
|
PreScription: First Estriol, Then What?
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 284
|
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
|
Jul/Aug 2008
Pg. 295-304
|
PreScription: Year Number 12…And Still Much Work to Do
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 4
|
Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC, Holmes Erin R
|
Jan/Feb 2008
Pg. 74-82
|
Acetylcysteine 200-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 417
|
Acetylcysteine 200-mg Packets
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 418
|
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 438-439
|
Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
|
Nov/Dec 2006
Pg. 434-435
|
Hospice Symptom Relief Kit: An Update
Petrin Ronald L
|
Jul/Aug 2006
Pg. 288-290
|
Granisetron 0.05-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 222
|
Mesna 20-mg/mL Syrup
Allen Loyd V Jr
|
May/Jun 2006
Pg. 224
|
Hospice from a Compounding Pharmacist's Perspective
Jones Marty
|
Mar/Apr 2006
Pg. 89-93
|
The Story of Hospice
Kuntz Rachael
|
Mar/Apr 2006
Pg. 100-102
|
| Return to Top |
